GlassScriptPhysician profile
Siobhan Kent
NPI 1730625880
$3,030.37
in general payments reported to CMS, 2019-2025
14 companies · $330 in 2025
The $330 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $765 · 2022: $1,198 · 2023: $433 · 2024: $304 · 2025: $330.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,067.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,067.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $491.80 | 2021-2025 | Ozempic |
| Sanofi-Aventis U.S. LLC | $461.94 | 2021-2023 | |
| Abbott Laboratories | $389.65 | 2022-2023 | Freestyle Libre 3 |
| Lilly USA, LLC | $368.83 | 2021-2024 | Mounjaro |
| Insulet Corporation | $300.62 | 2022-2025 | Omnipod |
| Astrazeneca Pharmaceuticals LP | $282.88 | 2021-2022 | |
| Tandem Diabetes Care, INC. | $183.89 | 2022-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Radius Health, INC. | $164.48 | 2021-2023 | Tymlos |
| Xeris Pharmaceuticals, INC. | $130.31 | 2021-2022 | |
| Silk Road Medical, INC. | $115.52 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Dexcom, INC. | $80.47 | 2022-2024 | Dexcom G6 Transmitter |
| Zealand Pharma US, INC. | $30.53 | 2021-2022 | |
| Becton, Dickinson and Company | $18.26 | 2022 | |
| Ibsa Pharma INC. | $11.19 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Siobhan Kent listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.